Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3 - PubMed (original) (raw)
. 2001 Jul 6;276(27):25309-17.
doi: 10.1074/jbc.M101914200. Epub 2001 Apr 20.
Affiliations
- PMID: 11316813
- DOI: 10.1074/jbc.M101914200
Free article
Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3
M Tachibana et al. J Biol Chem. 2001.
Free article
Abstract
The covalent modification of histone tails has regulatory roles in various nuclear processes, such as control of transcription and mitotic chromosome condensation. Among the different groups of enzymes known to catalyze the covalent modification, the most recent additions are the histone methyltransferases (HMTases), whose functions are now being characterized. Here we show that a SET domain-containing protein, G9a, is a novel mammalian lysine-preferring HMTase. Like Suv39 h1, the first identified lysine-preferring mammalian HMTase, G9a transfers methyl groups to the lysine residues of histone H3, but with a 10-20-fold higher activity. It was reported that lysines 4, 9, and 27 in H3 are methylated in mammalian cells. G9a was able to add methyl groups to lysine 27 as well as 9 in H3, compared with Suv39 h1, which was only able to methylate lysine 9. Our data clearly demonstrated that G9a has an enzymatic nature distinct from Suv39 h1 and its homologue h2. Finally, fluorescent protein-labeled G9a was shown to be localized in the nucleus but not in the repressive chromatin domains of centromeric loci, in which Suv39 h1 family proteins were localized. This finding indicates that G9a may contribute to the organization of the higher order chromatin structure of non-centromeric loci.
Similar articles
- G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis.
Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M, Takeda N, Niida H, Kato H, Shinkai Y. Tachibana M, et al. Genes Dev. 2002 Jul 15;16(14):1779-91. doi: 10.1101/gad.989402. Genes Dev. 2002. PMID: 12130538 Free PMC article. - Partitioning and plasticity of repressive histone methylation states in mammalian chromatin.
Peters AH, Kubicek S, Mechtler K, O'Sullivan RJ, Derijck AA, Perez-Burgos L, Kohlmaier A, Opravil S, Tachibana M, Shinkai Y, Martens JH, Jenuwein T. Peters AH, et al. Mol Cell. 2003 Dec;12(6):1577-89. doi: 10.1016/s1097-2765(03)00477-5. Mol Cell. 2003. PMID: 14690609 - Functional analysis of the N- and C-terminus of mammalian G9a histone H3 methyltransferase.
Estève PO, Patnaik D, Chin HG, Benner J, Teitell MA, Pradhan S. Estève PO, et al. Nucleic Acids Res. 2005 Jun 6;33(10):3211-23. doi: 10.1093/nar/gki635. Print 2005. Nucleic Acids Res. 2005. PMID: 15939934 Free PMC article. - The indexing potential of histone lysine methylation.
Schotta G, Lachner M, Peters AH, Jenuwein T. Schotta G, et al. Novartis Found Symp. 2004;259:22-37; discussion 37-47, 163-9. Novartis Found Symp. 2004. PMID: 15171245 Review. - Structure and function of histone H3 lysine 9 methyltransferases and demethylases.
Krishnan S, Horowitz S, Trievel RC. Krishnan S, et al. Chembiochem. 2011 Jan 24;12(2):254-63. doi: 10.1002/cbic.201000545. Epub 2011 Jan 5. Chembiochem. 2011. PMID: 21243713 Review.
Cited by
- The histone H3K9 methyltransferase G9a regulates tendon formation during development.
Wada S, Ideno H, Nakashima K, Komatsu K, Demura N, Tomonari H, Kimura H, Tachibana M, Nifuji A. Wada S, et al. Sci Rep. 2024 Sep 5;14(1):20771. doi: 10.1038/s41598-024-71570-5. Sci Rep. 2024. PMID: 39237663 Free PMC article. - PHD-BAH Domain in ASH1L Could Recognize H3K4 Methylation and Regulate the Malignant Behavior of Cholangiocarcinoma.
Zhang XY, Li Y. Zhang XY, et al. Anticancer Agents Med Chem. 2024;24(17):1264-1274. doi: 10.2174/0118715206312004240712072532. Anticancer Agents Med Chem. 2024. PMID: 39034728 - G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications.
Ni Y, Shi M, Liu L, Lin D, Zeng H, Ong C, Wang Y. Ni Y, et al. Cancers (Basel). 2024 Jun 8;16(12):2175. doi: 10.3390/cancers16122175. Cancers (Basel). 2024. PMID: 38927881 Free PMC article. Review. - Determinants of Chromatin Organization in Aging and Cancer-Emerging Opportunities for Epigenetic Therapies and AI Technology.
Castilho RM, Castilho LS, Palomares BH, Squarize CH. Castilho RM, et al. Genes (Basel). 2024 May 29;15(6):710. doi: 10.3390/genes15060710. Genes (Basel). 2024. PMID: 38927646 Free PMC article. Review. - Regulation of the Function and Expression of EpCAM.
Xiao D, Xiong M, Wang X, Lyu M, Sun H, Cui Y, Chen C, Jiang Z, Sun F. Xiao D, et al. Biomedicines. 2024 May 20;12(5):1129. doi: 10.3390/biomedicines12051129. Biomedicines. 2024. PMID: 38791091 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases